(E)-3-Naphthalen-2-yl-1-p-tolyl-propenone | 56412-58-9

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: (E)-3-Naphthalen-2-yl-1-p-tolyl-propenone
• 英文别名: 1-(4-methylphenyl)-3-naphthalen-2-ylprop-2-en-1-one
• CAS: 56412-58-9
• 化学式: C₂₀H₁₆O
• 分子量: 272.346
• InChiKey: AGWHYYNFZNUUDE-UHFFFAOYSA-N

物化性质

• 沸点：
  464.2±38.0 °C(Predicted)
• 密度：
  1.133±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5.04
• 重原子数：
  21.0
• 可旋转键数：
  3.0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.05
• 拓扑面积：
  17.07
• 氢给体数：
  0.0
• 氢受体数：
  1.0

反应信息

• 作为反应物：
  描述：

  (E)-3-Naphthalen-2-yl-1-p-tolyl-propenone 在 一水合肼 、 溶剂黄146 作用下， 以 甲醇 、 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 生成 (E)-N'-(3-methoxybenzylidene)-4-(5-(naphthalen-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)benzohydrazide
  参考文献：
  名称：

  含二氢吡唑作为潜在EGFR激酶抑制剂的苯并肼衍生物的设计，合成和生物学评估。

  摘要：

  已经合成了一系列含有二氢吡唑的新型苯并酰肼衍生物作为潜在的表皮生长因子受体（EGFR）激酶抑制剂，并评估了它们作为潜在的抗增殖剂的生物学活性。在这些化合物中，化合物H20对四种癌细胞系变体（A549，MCF-7，HeLa，HepG2）表现出最强的抗增殖活性，IC50值分别为0.46、0.29、0.15和0.21μM，显示出最强的EGFR抑制作用活性（EGFR的IC50 = 0.08μM）。为了预测这些苯并酰肼衍生物的生物活性和活性关系（SAR），进行了分子模型模拟研究。这些结果表明，化合物H20可能是有前途的抗癌药。

  DOI：

  10.3390/molecules21081012
• 作为产物：
  描述：

  2-萘甲醛 、 对甲基苯乙酮 在 potassium hydroxide 作用下， 以 乙醇 为溶剂， 生成 (E)-3-Naphthalen-2-yl-1-p-tolyl-propenone
  参考文献：
  名称：

  含二氢吡唑作为潜在EGFR激酶抑制剂的苯并肼衍生物的设计，合成和生物学评估。

  摘要：

  已经合成了一系列含有二氢吡唑的新型苯并酰肼衍生物作为潜在的表皮生长因子受体（EGFR）激酶抑制剂，并评估了它们作为潜在的抗增殖剂的生物学活性。在这些化合物中，化合物H20对四种癌细胞系变体（A549，MCF-7，HeLa，HepG2）表现出最强的抗增殖活性，IC50值分别为0.46、0.29、0.15和0.21μM，显示出最强的EGFR抑制作用活性（EGFR的IC50 = 0.08μM）。为了预测这些苯并酰肼衍生物的生物活性和活性关系（SAR），进行了分子模型模拟研究。这些结果表明，化合物H20可能是有前途的抗癌药。

  DOI：

  10.3390/molecules21081012

文献信息

• Co–N–C Catalyst for C–C Coupling Reactions: On the Catalytic Performance and Active Sites
  作者：Leilei Zhang、Aiqin Wang、Wentao Wang、Yanqiang Huang、Xiaoyan Liu、Shu Miao、Jingyue Liu、Tao Zhang

  DOI：10.1021/acscatal.5b01223

  日期：2015.11.6

  simple substrates. However, they usually involve the employment of organic halides and suffer from toxic or environmental issues. We report an efficient and environmentally benign methodology—aerobic oxidative cross-coupling of primary and secondary alcohols—to directly produce α,β-unsaturated ketones that are key intermediates for synthesis of agrochemical, pharmaceutical, and other fine chemicals. A noble-metal-free

  C–C键形成反应在化学中对于从容易获得的简单底物构建复杂大分子非常重要。但是，它们通常涉及有机卤化物的使用，并且具有毒性或环境问题。我们报告了一种有效且对环境无害的方法-伯醇和仲醇的好氧氧化交叉偶联-直接生产α，β-不饱和酮，这是合成农业化学，制药和其他精细化学品的关键中间体。一种无贵金属的Co–N–C催化剂，是由钴-菲咯啉配合物在中孔碳载体上热解衍生而来的，可用于目标反应，并具有很高的催化活性（转换频率为3.8 s –1基于Co的单原子，超过了文献中的技术水平），良好的可回收性以及对各种基材的广泛适用性（28个示例）。有人建议在Co–N–C催化剂中的活性位是在石墨薄片内与N键合的Co单原子。
• Site-selective carbonylation of arenes via C(sp2)-H thianthrenation: Palladium-catalyzed direct access to α,β-unsaturated ketones
  作者：Jiajun Zhang、Le-Cheng Wang、Yuanrui Wang、Bing-Hong Teng、Xiao-Feng Wu

  DOI：10.1016/j.jcat.2024.115454

  日期：2024.4

  palladium-catalyzed carbonylative Heck reaction of aryl thianthrenium salts with carbon monoxide and alkenes has been developed. This protocol can greatly reduce the quantity of olefins used in the carbonylative Heck reaction. In addition, the reaction can also proceed when the coupling partner is a non-activated olefin which is not common in such carbonylative Heck reactions. Combined with C–H thianthrenation

  在此，开发了一种有效的钯催化的芳基铊盐与一氧化碳和烯烃的羰基化 Heck 反应。该方案可以大大减少羰基化Heck反应中使用的烯烃的量。此外，当偶联配对物是在此类羰基化Heck反应中不常见的非活化烯烃时，该反应也可以进行。结合芳烃的C-H噻嗪化反应，该工作为芳烃的位点选择性C-H羰基化Heck反应提供了一种有效的方法。它可能作为未来复杂分子修饰的重要后期羰基化工具。
• Synthesis and biological evaluation of compounds which contain pyrazole, thiazole and naphthalene ring as antitumor agents
  作者：Ji-Wen Yuan、She-Feng Wang、Zhong-Liang Luo、Han-Yue Qiu、Peng-Fei Wang、Xin Zhang、Yong-An Yang、Yong Yin、Fei Zhang、Hai-Liang Zhu

  DOI：10.1016/j.bmcl.2014.03.072

  日期：2014.5

  A series of compounds which contain pyrazole, thiazole and naphthalene ring (1a-7a, 1b-7b, 1c-7c, 1d-7d) were firstly synthesized and their anti-proliferative activity, EGFR inhibitory activity, cytotoxicity and inhibition to Hela cell migration were evaluated. Compound 2-(3-(3,4-dimethylphenyl)-5-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl) thiazol-4(5H)-one (7d) displayed the most potent inhibitory activity (IC50 = 0.86 mu M for Hela and IC50 = 0.12 mu M for EGFR). Structure-activity relationship (SAR) analysis showed that the anti-proliferative activity was affected by A-ring-substituent (-OCH3 > -CH3 > -H > -Br > -Cl > -F). Docking simulation of compound 7d into EGFR active site showed that naphthalene ring of 7d with LYS721 formed two p-pi bonds, which enhanced antitumor activity. Therefore, compound 7d may be developed as a potential antitumor agent. (C) 2014 Elsevier Ltd. All rights reserved.
• Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis
  作者：Xiao-Qiang Yan、Zhong-Chang Wang、Zhen Li、Peng-Fei Wang、Han-Yue Qiu、Long-Wang Chen、Xiao-Yuan Lu、Peng-Cheng Lv、Hai-Liang Zhu

  DOI：10.1016/j.bmcl.2015.08.026

  日期：2015.10

  New series of sulfonamide derivatives containing a dihydropyrazole moieties inhibitors of MMP-2/MMP-9 were discovered using structure-based drug design. Synthesis, antitumor activity, structure-activity relationship and optimization of physicochemical properties were described. In vitro the bioassay results revealed that most target compounds showed potent inhibitory activity in the enzymatic and cellular assays. Among the compounds, compound 3i exhibited the most potent inhibitory activity with IC50 values of 0.21 mu M inhibiting MMP-2 and 1.87 mu M inhibiting MMP-9, comparable to the control positive compound CMT-1 (1.26 mu M, 2.52 mu M). Docking simulation was performed to position compound 3i into the MMP-2 active site to determine the probable binding pose. Docking simulation was further performed to position compound 3i into the MMP-2 active site to determine the probable binding model the 3D-QSAR models were built for reasonable design of MMP-2/MMP-9 inhibitors at present and in future. (C) 2015 Elsevier Ltd. All rights reserved.